Pengguang Wu

Dr. Wu is interested in healthcare, mobile health, and internet of things. He previously worked at Exelixis in the area of assay development, high throughput screening, compound management, and translational medicine biorepository in oncology. Proior to that, he worked at Tularik in assay development,  screening, and lead optimization in anti-infectives, immunology/inflammation, and oncology. He obtained his BSc in chemistry from Shandong University, China. His PhD was in physical chemistry of nucleic acid/drug complex from the Department of Chemistry, University of Washington, Seattle. He did a postdoc studying DNAs with modified bases in the Departments of Physics and Biophysics at University of Rochester, Rochester, New York. He did another postdoc studying protein folding in the Department of Biology, Johns Hopkins University, Baltimore, MD.